Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Personalis, Inc.

< Previous 1 2 3 4 Next >
Personalis to Announce Second Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Reports First Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present at Upcoming Investor Conferences
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Announce First Quarter 2022 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Reports Fourth Quarter and Full Year 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present at the Cowen 42nd Annual Health Care Conference
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Announces Collaboration with UC San Diego Moores Cancer Center for Clinical Genomic Testing and Research into Composite Biomarkers and Minimal Residual Disease Detection
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Announce Fourth Quarter and Full-Year Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Participate in the 24th Annual Needham Virtual Growth Conference
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Named to Inc.'s 2021 Best-Led Companies List
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Present New Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Reports Third Quarter 2021 Financial Results
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Announces Updates to NeXT Platform™ Incorporating Additional Key Profiling Capabilities for Advancing Oncology Biomarkers
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Announces Issuance of US Patents Related to the Exome-Wide NeXT Liquid Biopsy Platform
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Publishes New Data Demonstrating Performance and Utility of SHERPA for High-Accuracy Neoantigen Prediction and Cancer Diagnostic Biomarker Development
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis to Announce Third Quarter Financial Results on November 4, 2021
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Expands Leadership Team With Appointment of Robert Bruce, Vice President of Reimbursement
From Personalis, Inc.
Via Business Wire
Tickers PSNL
Personalis Receives New VA MVP Task Order and Record Quarterly Orders From Oncology Customers; Reconfirms Total Revenue Outlook for 2021 with Further Accelerated Oncology Growth
From Personalis, Inc.
Via Business Wire
Tickers PSNL
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.